Beyond Air, Inc. (XAIR | DoD: +58.69% | YTD: -20.66% | SmallCap: 16M)

• Profile: A company committed to revolutionizing nitric oxide therapy with the LungFit product family
• Reporting: Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update (Full Text)

Illumina, Inc. (ILMN | DoD: -0.86% | YTD: -31.67% | MidCap: 12.9B)

• Profile: Provides sequencing- and array-based solutions for genetic and genomic analysis
• Financing: Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling (Full Text)

Prenetics Global Limited (PRE | DoD: +7.13% | YTD: +32.22% | SmallCap: 120M)

• Profile: A leading health sciences company
• Financing: Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board (Full Text)

Prenetics Global Limited (PRE | DoD: +7.13% | YTD: +32.22% | SmallCap: 120M)

• Profile: A leading health sciences company
• Acquisition: Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction (Full Text)

Smith & Nephew plc (SNN | DoD: -2.32% | YTD: +19.27% | MidCap: 12.7B)

• Profile: The global medical technology company
• Partnership: Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK (Full Text)

Aethlon Medical, Inc. (AEMD | DoD: -1.67% | YTD: -72.34% | SmallCap: 6M)

• Profile: A medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases
• Clinical: Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial (Full Text)

GRAIL, Inc. (GRAL | DoD: -1.11% | YTD: +134.65% | MidCap: 1.4B)

• Profile: A commercial-stage healthcare company, provides multi-cancer early detection testing and services
• Clinical: GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study (Full Text)

Align Technology, Inc. (ALGN | DoD: -4.03% | YTD: -15.99% | MidCap: 12.9B)

• Profile: A leading global medical device company that designs, manufactures, and sells the Invisalign¬Æ System of clear aligners
• Product: Align Technology Launches Integrated Consumer and Professional Brand Campaign Focused on Invisalign® Treatment for Kids and Teens (Full Text)

Ekso Bionics Holdings, Inc. (EKSO | DoD: +1.04% | YTD: -58.23% | SmallCap: 154M)

• Profile: An industry leader in exoskeleton technology for medical and industrial use
• Partnership: Ekso Bionics' Acceptance into NVIDIA Connect Program Bears Early Fruit (Full Text)

INVO Fertility, Inc. (IVF | DoD: -5.30% | YTD: -87.60% | SmallCap: 3M)

• Profile: Focuses on the fertility marketplace that provides assisted reproductive technology care to patients
• Product: INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute (Full Text)

Intelligent Bio Solutions Inc. (INBS | DoD: +1.58% | YTD: +36.88% | SmallCap: 10M)

• Profile: A medical technology company, developing rapid, non-invasive testing, and screening solutions
• Product: Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion (Full Text)

Sharps Technology, Inc. (STSS | DoD: -6.88% | YTD: -99.21% | SmallCap: 4M)

• Profile: A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products
• Product: Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades (Full Text)

Ainos, Inc. (AIMD | DoD: +5.84% | YTD: +6.60% | SmallCap: 14M)

• Profile: A healthcare company, focuses on the development of novel point-of-care testing therapeutics based on very low-dose interferon alpha and synthetic RNA-driven preventative medicine
• Report: Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25 (Full Text)

DexCom, Inc. (DXCM | DoD: -1.41% | YTD: +4.24% | LargeCap: 33.9B)

• Profile: Developer of innovative technologies that transform how people manage diabetes and track their glucose
• Report: Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 (Full Text)

Myomo, Inc. (MYO | DoD: -1.43% | YTD: -57.56% | SmallCap: 104M)

• Profile: A wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis
• Event: Myomo Provides Highlights of Today's Investor & Analyst Day Event (Full Text)

Solventum Corporation (SOLV | DoD: -2.27% | YTD: +10.36% | MidCap: 12.8B)

• Profile: A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs
• Award: Solventum Named a Best Company to Work for by U.S. News & World Report (Full Text)

Applied DNA Sciences, Inc. (APDN | DoD: -7.62% | YTD: -97.45% | SmallCap: 38M)

• Profile: A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA)
• Leadership Update: Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward (Full Text)